Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.
Quadrant Private Equity has acquired Australia-based childcare business Affinity Education from Anchorage Capital Partners for A$650 million ($490 million).
KKR has agreed to pay $625 million for a controlling stake in Vini Cosmetics, a leading branded personal care and beauty products company in India.
Nuevocor, a preclinical biotech company specializing in gene therapy for heart disease, has closed an oversubscribed Series A round with $24 million in commitments.
Apis Partners has led a $45 million Series C round for RenewBuy, an India insurance comparison platform specializing in motor insurance.
Venturous Group, a Chinese smart city platform, has received $131 million in Series A funding from Fidelity, several family offices, and Benson Tan, founder of Venturous.
PAG Asia Capital-backed China Youran Dairy Group raised HK$4.99 billion ($643 million) through a Hong Kong IPO but then ended its trading debut below the IPO price.
New Zealand private equity firm Oriens Capital has hit the NZ$80 million ($56 million) target for its second fund and is now seeking NZ$20 million in oversubscriptions.
Nutshell Therapeutics, a Chinese drug developer, has raised a $20 million Series A round led by Matrix Partners China.
Zhuanzhuan, a used goods trading platform and subsidiary of 58.com, China’s largest online classifieds marketplace, has raised a $100 million round led by electronics giant Xiaomi.
KPCB growth-stage spinout Bond has led a $200 million Series B round for BrowserStack, a software testing platform established by two Indian entrepreneurs.
Chinese healthcare big data company LinkDoc Technology, which counts New Enterprise Associates (NEA), China Broadband Capital, and Temasek Holdings among its investors, has filed for an IPO in the US.
Yonghe Medical Group, a Chinese hair healthcare specialist best known for hair transplants, is targeting a Hong Kong IPO. Its largest external shareholder is CPE, formerly CITIC Private Equity.
Venturi Partners, a Singapore-based consumer-focused investment firm established by a former Verlinvest executive in the region, has completed a $100 million first close on its debut fund.
FamPay, an Indian start-up aiming to launch the country’s first digital bank for teenagers, has raised a $38 million Series A round led by Elevation Capital.
Insight Partners and Tiger Global Management have led a $70 million Series B round for Apna, an Indian professional networking and jobs platform.
ENA Respiratory, an Australian biotech company developing a nasal spray for the prevention of COVID-19, has raised A$32 million ($25 million) with support from local venture capital investor Brandon Capital.
Joy Capital and Nio Capital will invest $315 million in China-based online used car dealer Uxin, throwing their support behind the company’s pivot from a marketplace to an inventory-holding retailer.
Xiaoe Tong, a Chinese software-as-a-service (SaaS) provider that integrates its products with WeChat, has raised $120 million in Series D funding led by IDG Capital.
Indian education platform Byju’s has raised about $340 million at a post-money valuation of $16.5 billion from investors including The Blackstone Group.
More than half of LPs continue to establish new GP relationships at the same rate as before the pandemic, according to the latest installment of Coller Capital’s global private equity barometer survey.
Chinese B2B pharmaceutical trading platform Yaoshibang has raised $270 million from Guangdong Pearl River Investment, Baidu, Sunshine Insurance, Green Pine Capital Partners, Guangzhou government-backed S Fund, and an undisclosed sovereign wealth fund.